Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47Lung Neoplasms 43Neoplasm Metastasis 34Carcinoma, Non-Small-Cell Lung 33Breast Neoplasms 26Multiple Myeloma 24Glioma 22Pancreatic Neoplasms 21Carcinoma, Renal Cell 21Lymphoma, Large B-Cell, Diffuse 20Ovarian Neoplasms 19Melanoma 19Glioblastoma 19Squamous Cell Carcinoma of Head and Neck 18Lymphoma 18Urinary Bladder Neoplasms 17Colorectal Neoplasms 17Oropharyngeal Neoplasms 15Mouth Neoplasms 15Triple Negative Breast Neoplasms 14Brain Neoplasms 14Fallopian Tube Neoplasms 13Carcinoma 13Laryngeal Neoplasms 12Carcinoma, Hepatocellular 12Astrocytoma 12Leukemia, Myeloid, Acute 11Sarcoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neuroblastoma 10

Interventions

Gemcitabine 10Mitomycin 6Docetaxel 5erdafitinib 4durvalumab 4BCG Vaccine 4dodecyl maltoside 3Cystoscopy 3ALT-803 2viscum album peptide 1tremelimumab 1pirarubicin 1monalizumab 1hydroxycamptothecinum 1chondroitin sulfate, sodium hyaluronate drug combination 1Watchful Waiting 1Transurethral Resection of Bladder 1Patient Discharge 1Mitozytrex 1Magnetic Resonance Spectroscopy 1Injections 1Hyaluronic Acid 1House Calls 1Home Care Services 1Epirubicin 1Drainage 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Chondroitin Sulfates 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Magnetic Resonance Spectroscopy × 90 days × Clear all
NCT07000084 2026-06-02

GAIN-BCG

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
330 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡